Zurich Cantonal Bank’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $17.9M | Buy |
373,042
+54,749
| +17% | +$2.4M | 0.04% | 371 |
|
|
2025
Q4 | $12.3M | Buy |
318,293
+219,479
| +222% | +$8.37M | 0.04% | 450 |
|
|
2025
Q3 | $3.49M | Sell |
98,814
-12,732
| -11% | -$461K | 0.01% | 706 |
|
|
2025
Q2 | $4.02M | Sell |
111,546
-16,668
| -13% | -$552K | 0.01% | 641 |
|
|
2025
Q1 | $3.99M | Sell |
128,214
-47,438
| -27% | -$1.5M | 0.01% | 635 |
|
|
2024
Q4 | $4.48M | Buy |
175,652
+18,207
| +12% | +$483K | 0.01% | 621 |
|
|
2024
Q3 | $4.44M | Sell |
157,445
-6,489
| -4% | -$180K | 0.01% | 603 |
|
|
2024
Q2 | $4.37M | Sell |
163,934
-7,727
| -5% | -$214K | 0.01% | 580 |
|
|
2024
Q1 | $5.23M | Buy |
171,661
+31,249
| +22% | +$921K | 0.02% | 540 |
|
|
2023
Q4 | $3.94M | Sell |
140,412
-69,164
| -33% | -$1.9M | 0.02% | 588 |
|
|
2023
Q3 | $5.61M | Buy |
209,576
+90,282
| +76% | +$2.68M | 0.02% | 488 |
|
|
2023
Q2 | $3.65M | Buy |
119,294
+32,161
| +37% | +$1.09M | 0.02% | 581 |
|
|
2023
Q1 | $3.16M | Buy |
87,133
+18,609
| +27% | +$690K | 0.02% | 595 |
|
|
2022
Q4 | $2.71M | Buy |
68,524
+8,963
| +15% | +$374K | 0.01% | 608 |
|
|
2022
Q3 | $2.39M | Buy |
59,561
+10,319
| +21% | +$441K | 0.01% | 625 |
|
|
2022
Q2 | $2.07M | Sell |
49,242
-36
| -0.1% | -$1.48K | 0.01% | 668 |
|
|
2022
Q1 | $1.92M | Buy |
49,278
+13,787
| +39% | +$541K | 0.01% | 732 |
|
|
2021
Q4 | $1.41M | Buy |
35,491
+6,221
| +21% | +$242K | 0.01% | 860 |
|
|
2021
Q3 | $1.07M | Sell |
29,270
-143
| -0.5% | -$5.56K | 0.01% | 904 |
|
|
2021
Q2 | $1.21M | Hold |
29,413
| – | – | 0.01% | 842 |
|
|
2021
Q1 | $1.28M | Buy |
29,413
+5,142
| +21% | +$244K | 0.01% | 812 |
|
|
2020
Q4 | $1.22M | Buy |
+24,271
| New | +$1.03M | 0.01% | 880 |
|
Other funds holding RPRX
